EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 32011D0091
2011/91/EU: Commission Decision of 10 February 2011 authorising a laboratory in the Republic of Korea to carry out serological tests to monitor the effectiveness of rabies vaccines (notified under document C(2011) 656) Text with EEA relevance
2011/91/EU: Commission Decision of 10 February 2011 authorising a laboratory in the Republic of Korea to carry out serological tests to monitor the effectiveness of rabies vaccines (notified under document C(2011) 656) Text with EEA relevance
2011/91/EU: Commission Decision of 10 February 2011 authorising a laboratory in the Republic of Korea to carry out serological tests to monitor the effectiveness of rabies vaccines (notified under document C(2011) 656) Text with EEA relevance
OJ L 37, 11.2.2011, p. 18–18
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
- Date of document:
- 10/02/2011
- Date of effect:
- 11/02/2011; Takes effect Date notif.
- Date of effect:
- 01/03/2011; Application See Art 2
- Date of notification:
- 11/02/2011
- Date of end of validity:
- No end date
- Author:
- European Commission
- Responsible body:
- Directorate-General for Health and Food Safety
- Form:
- Decision
- Addressee:
- The twenty-seven Member States: Belgium, Bulgaria, Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden, United Kingdom
- Additional information:
- EEA relevance
- Treaty:
- Treaty on the Functioning of the European Union
- Legal basis:
-
- 32000D0258 - A03P2
- Link
- Link
- Link
- Select all documents mentioning this document
- Link
- EUROVOC descriptor:
- Subject matter:
- Directory code:
|
11.2.2011 |
EN |
Official Journal of the European Union |
L 37/18 |
COMMISSION DECISION
of 10 February 2011
authorising a laboratory in the Republic of Korea to carry out serological tests to monitor the effectiveness of rabies vaccines
(notified under document C(2011) 656)
(Text with EEA relevance)
(2011/91/EU)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Council Decision 2000/258/EC of 20 March 2000 designating a specific institute responsible for establishing the criteria necessary for standardising the serological tests to monitor the effectiveness of rabies vaccines (1), and in particular Article 3(2) thereof,
Whereas:
|
(1) |
Decision 2000/258/EC designates the laboratory of the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail (ANSES) in Nancy (previously Agence française de sécurité sanitaire des aliments (AFSSA)) as the specific institute responsible for establishing the criteria necessary for standardising the serological tests to monitor the effectiveness of rabies vaccines. That Decision also lays down the duties of that laboratory. |
|
(2) |
In particular, ANSES, Nancy, is to appraise the laboratories in Member States and third countries in order to decide whether to authorise the laboratories to carry out serological tests to monitor the effectiveness of rabies vaccines. |
|
(3) |
The competent authority of South Korea has submitted an application for approval of a laboratory in that third country to perform such serological tests. |
|
(4) |
ANSES, Nancy has carried out an appraisal of that laboratory and provided the Commission with a favourable report of that appraisal on 6 September 2010. |
|
(5) |
That laboratory should therefore be authorised to carry out serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets. |
|
(6) |
The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health, |
HAS ADOPTED THIS DECISION:
Article 1
In accordance with Article 3(2) of Decision 2000/258/EC, the following laboratory is authorised to perform the serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets:
|
Komipharm International Co. Ltd |
|
1236-6 Jeoungwang-dong |
|
420-450 Siheung-si, Gyeonggi-do |
|
South Korea |
Article 2
This Decision shall apply from 1 March 2011.
Article 3
This Decision is addressed to the Member States.
Done at Brussels, 10 February 2011.
For the Commission
John DALLI
Member of the Commission
